RNA Manufacturing Resources
-
Exosome Isolation By TFF And Size Exclusion Chromatography
3/6/2024
Here, we demonstrate a scalable workflow for the isolation of exosomes that combines tangential flow filtration for the concentration of exosomes followed by gentle size exclusion chromatography.
-
Establishing Analytical Methods For mRNA-Based Therapies
6/13/2023
Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.
-
Oligonucleotide Development And Manufacturing Workflow
3/28/2022
Learn more about oligo workflows and solutions for oligonucleotide process development, from scalable oligo synthesis to cleavage and deprotection, purification, and buffer exchange.
-
The Crucial Role Of Downstream Processing In Optimizing RNA-LNP Drug Development
8/28/2024
Explore the key aspects of lipid nanoparticle (LNP) development, including the essential downstream processes of Tangential Flow Filtration (TFF) and normal flow filtration.
-
Size Matters: Mastering Size Exclusion For Oligos
12/15/2025
Learn how to separate molecules strictly by size, effectively remove salts, and select the correct pore specifications for a gentle, non-destructive purification workflow.
-
Best Practices For Analysis Of In Vitro Transcribed (IVT) mRNA
11/20/2025
Learn best practices for high-resolution analysis of IVT RNA using automated capillary electrophoresis. Improve accuracy and precision in quantifying critical quality attributes.
-
How mRNA Technology Is Shaping The Future Of Medicine
1/4/2022
Discover how mRNA technologies open the doors to a whole range of new gene therapies and the role of lipid nanoparticles (LNPs) in current and future developments.
-
Next-Gen Bioprocess Monitoring: Smart Data Management And Analysis
10/14/2020
A new platform that includes digital technologies/data management, process analytical technologies and intensified processing will drive next generation bioprocessing.
-
How Data Analytics Accelerates Transition To Bioprocessing 4.0
4/7/2023
Following successful Industry 4.0 implementation in the automotive, communications, aerospace, and other industries, the biopharma industry is now joining the digital revolution.
-
The Power Couple: CRISPR And Oligonucleotides
3/4/2024
Drug design using CRISPR depends on long guide RNA (gRNA) sequences. Find out how this match between long oligos and CRISPR works.